Latest news, press releases, and SEC filings for ACADIA Pharmaceuticals Inc (ACAD) https://caymanjournal.com/stock/ACAD en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 21:11:30 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is ACADIA Pharmaceuticals' **Annual Report to Shareholders (ARS)**. Think of it as the company's yearly "highlight reel" sent directly to its investors. It's designed to be more visual and narrative than a strict regulatory filing, summarizing performance, strategy, a https://caymanjournal.com/stock/ACAD/sec-filing/0001193125-26-174167 https://caymanjournal.com/stock/ACAD/sec-filing/0001193125-26-174167 Fri, 24 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **Definitive Proxy Statement (DEF 14A)** for **ACADIA Pharmaceuticals Inc.** Think of it as the official invitation and instruction manual for the company's annual shareholder meeting. It tells shareholders what will be voted on, provides background on the compan https://caymanjournal.com/stock/ACAD/sec-filing/0001193125-26-174163 https://caymanjournal.com/stock/ACAD/sec-filing/0001193125-26-174163 Fri, 24 Apr 2026 00:00:00 GMT SEC Filing